Insulet
PODD
144 hedge funds and large institutions have $1.57B invested in Insulet in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 53 increasing their positions, 52 reducing their positions, and 30 closing their positions.
142% more call options, than puts
Call options by funds: $1.14M | Put options by funds: $470K
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
2% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 52
6% less funds holding
Funds holding: 153 → 144 (-9)
17% less capital invested
Capital invested by funds: $1.88B → $1.57B (-$311M)
27% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VM
Valinor Management
New York
|
+$84.7M |
| 2 |
TI
Think Investments
San Francisco,
California
|
+$33.4M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$14M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$11.4M |
| 5 |
Morgan Stanley
New York
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$35.8M |
| 2 |
Millennium Management
New York
|
-$32.9M |
| 3 |
DCM
Daruma Capital Management
New York
|
-$22.3M |
| 4 |
VAM
Visium Asset Management
New York
|
-$18.6M |
| 5 |
O
OrbiMed
New York
|
-$14M |
PODD Hedge Fund Activity: Q3 2015 in Review
144 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2015, worth a combined $1.57B — down 17% from $1.88B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of PODD and 22 opened new positions — a net loss of 8 holders — while 52 trimmed existing stakes and 53 added.
The largest buyer was Valinor Management, opening a new position worth an estimated $84.7M. The largest seller was JP Morgan Chase, cutting an estimated $35.8M.
- 144 institutional investors held Insulet (PODD) as of Q3 2015, down from 153 in Q2 2015.
- Funds reported $1.57B of Insulet stock for Q3 2015, down 17% quarter-over-quarter.
- 22 funds opened new Insulet positions in Q3 2015 and 30 closed out, a net change of -8 holders.
- The largest Insulet buyer in Q3 2015 was Valinor Management, an estimated $84.7M added.
- The largest Insulet seller in Q3 2015 was JP Morgan Chase, an estimated $35.8M sold.
Based on aggregated 13F filings for Q3 2015.